Sign in to view Robert’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Robert’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
San Francisco, California, United States
Sign in to view Robert’s full profile
Robert can introduce you to 7 people at StandardC
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
6K followers
500+ connections
Sign in to view Robert’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Robert
Robert can introduce you to 7 people at StandardC
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Robert
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Robert’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Websites
- Company Website
-
www.standardc.com
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Articles by Robert
-
You are absolutely right, and that is the problem.
You are absolutely right, and that is the problem.
The Examiner Does Not Want Your Best Prompt AI is trained to agree with you and built to sample. A financial…
14
2 Comments -
My Message from AI CentralFeb 28, 2026
My Message from AI Central
What 25 Years in Silicon Valley Taught Me About AI and Institutional Trust I have lived and worked in San Francisco and…
37
6 Comments -
Before AI Was AI: What Building Predictive Systems at Mrs. Fields Taught Me About Banking TodayFeb 15, 2026
Before AI Was AI: What Building Predictive Systems at Mrs. Fields Taught Me About Banking Today
Mrs. Fields Cookies was a Palo Alto startup before anyone used the word startup.
63
1 Comment -
The Reality Mandate 2026: Strategic Verification When Documents No Longer Prove RealityJan 4, 2026
The Reality Mandate 2026: Strategic Verification When Documents No Longer Prove Reality
The Structural Shift in Financial Integrity The financial services ecosystem entering 2026 faces a profound structural…
54
4 Comments -
AI or Real? The End of Digital Trust and the Case for Mandating RealityDec 19, 2025
AI or Real? The End of Digital Trust and the Case for Mandating Reality
The End of Digital Trust and the Case for Mandating Reality The collapse of digital trust is no longer a theoretical…
77
4 Comments
Activity
6K followers
-
Robert Mann shared thisTHE ALIEN IN THE VAULT Bill Gates told CNN's Fareed Zakaria GPS on Sunday that AI is "a new alien species that is going to be smarter than we are." Most banks are answering that alien with a policy memo. Six months ago, Mike Freiling, PhD (MIT AI Lab, advisor to StandardC) wrote that generative AI is a supernova, "...throwing off new capabilities and new risks almost every day." His conclusion: "The genAI supernova will continue to explode." Both agree on what matters for banks. Nobody is coming to govern this for you. Gates says society has not caught up to how powerful AI is. Freiling is blunter: "Guarantees of confidentiality by third-party vendors cannot be relied upon." The question for every bank CEO, CRO, and BSA officer: If an alien intelligence is already reading your customer files through a chatbot tab, who is watching it? Governing AI in a bank is not a ban. It is four things: 1. Private data is removed before any model sees it. 2. Numbers calculated by code, not generated. 3. Every finding is traced to its source. 4. A human decision on the record. Gates also argued that a monitoring layer over AI can be built without significantly slowing progress. Banks can build their solution this quarter with StandardC Privacy First AI. Read the full article before your next board meeting: Mike Freiling's risk framework and five questions every board should ask about AI. What is your institution doing about the alien in the vault? https://lnkd.in/gBCBNK57 #AIGovernance #Banking #CommunityBanks #CreditUnions #PrivacyFirstAI
-
Robert Mann shared thisLook closely at the second line of this image. The AI that generated it dropped a letter from "dressed." One letter. In a sentence about its own limits. It rendered the picture beautifully, got 99% of the words right, and delivered the result with total confidence. I kept it, because that is the whole argument in one frame: the error is small, plausible, and easy to miss, and nothing in the system knew it was there. The line belongs to Mark Smillie, author of The Feeling Machine, and he backs it with a patient. Elliot had surgery that cut the link between his emotions and his reasoning. IQ untouched. Memory untouched. And he could no longer make a decent decision. He could analyze every option and choose none of them well. That is a large language model. Brilliant, tireless, and constitutionally unable to tell what matters. As Mike Freiling, MIT AI PhD and CFA, put it on our webinar, machine intelligence is alien. It weighs everything equally because it has never lived through anything. It will hand you a 94% confidence score with the same composure whether it is looking at a loan file, a school, or a word it just misspelled. Now put that one-letter error in a debt service coverage ratio. So here is my question for banking executives and the investors backing AI in banking: why buy a system that is built to decide? We built StandardC AI on the opposite premise. Governed agents instead of prompts, so the institution's own policies define what the system reads, checks and cites. Deterministic code runs the ratios and reconciliations; the model only interprets. Private data is tokenized before the model sees a byte. Every finding cites its source and every run is reproducible. The system puts the application, the tax return, the P&L and the core deposit history side by side and shows a human where they disagree. The human, the one with a body, a career and a signature, decides. Bankers: ask your vendor who signs when the model is 94% sure and wrong. Investors: ask whether the company you are backing can survive that question in a regulator's office. Then watch the conversation that started this: https://lnkd.in/g7gVethZ #AI #Banking #AIGovernance #Fintech #VentureCapital #HumanJudgment
-
Robert Mann shared thisEveryone's racing to take humans out of the loop. We think that's the mistake of the decade. Today at 2 PM Pacific, StandardC's Robert Baron, Mark Smillie (author of The Feeling Machine), and Mike Freiling, PhD, get into why AI can out-calculate you but will never out-judge you, and what that costs you the moment the stakes are real. "Judgment Without Feeling? Human vs. Artificial Intelligence" Register: https://lnkd.in/g235sWPH #AI #ArtificialIntelligence #HumanInTheLoopWelcome! You are invited to join a webinar: Judgment Without Feeling? Human vs. Artificial Intelligence. After registering, you will receive a confirmation email about joining the webinar.Welcome! You are invited to join a webinar: Judgment Without Feeling? Human vs. Artificial Intelligence. After registering, you will receive a confirmation email about joining the webinar.
-
Robert Mann shared thisEveryone's racing to take humans out of the loop. We think that's the mistake of the decade. Today at 2 PM Pacific, StandardC's Robert Baron, Mark Smillie (author of The Feeling Machine), and Mike Freiling, PhD, get into why AI can out-calculate you but will never out-judge you, and what that costs you the moment the stakes are real. "Judgment Without Feeling? Human vs. Artificial Intelligence" Register: https://lnkd.in/g235sWPH #AI #ArtificialIntelligence #HumanInTheLoop
-
Robert Mann shared thisUnintentional AI sharing. Confident wrong numbers - AI hallucinations. Both are fixable, the one that is not: a generation that never learned to disagree with the machine. Join us on September 23 for a lively discussion about enhancing human judgment with AI.Robert Mann shared thisCan a machine have judgment without feeling? Join StandardC for a live fireside conversation with Mark Smillie, author of The Feeling Machine, and Mike Freiling, PhD, moderated by StandardC Chief Experience Officer Robert Baron. We will dig into where AI decisioning ends and human judgment begins, the dependency trap that erodes expertise, and what it all means for high-stakes regulated work. #ArtificialIntelligence #HumanInTheLoop #BSA #AML #Compliance #Fintech #AI
-
Robert Mann shared thisIs your company building AI that makes you smarter? Or obsolete? Mike Freiling was working in AI at MIT decades before most of us had even heard the term. I've known Mark Smillie since he was an investment banker in the early days. On September 23rd, they're going head-to-head on whether judgment survives without feeling, and what that means for anyone building or relying on AI.Robert Mann shared thisCan a machine have judgment without feeling? Join StandardC for a live fireside conversation with Mark Smillie, author of The Feeling Machine, and Mike Freiling, PhD, moderated by StandardC Chief Experience Officer Robert Baron. We will dig into where AI decisioning ends and human judgment begins, the dependency trap that erodes expertise, and what it all means for high-stakes regulated work. #ArtificialIntelligence #HumanInTheLoop #BSA #AML #Compliance #Fintech #AI
-
Robert Mann shared thisThere is a disorder loose in regulated industries, and the people who have it think they are being productive. Prompting Disorder: refining prompt after prompt to get consistent results from a system that samples the data instead of reading it, and agrees with you because it was trained to. Alone, it costs an afternoon and a token bill that nobody budgeted for. Inside a bank, it costs a methodology: five analysts, forty prompts, different ratings for the same customer, no record of who asked what. Version control dies quietly. Confidence in every prior rating dies with it. That is a finding waiting for an examiner. We solved it, and the cure is boring on purpose. Open the article. At a minimum, learn about the disease before it infects your next audit.You are absolutely right, and that is the problem.You are absolutely right, and that is the problem.Robert Mann
-
-
Robert Mann shared thisMy co-founder Richard Laiderman wrote the essay below about a Go match, and it ends up explaining most of what worries me about AI in banking. His framework is simple. When you are ahead, you reduce risk to protect your lead. When you are behind, you gamble, because a Hail Mary is your best remaining chance. Sound strategy on a Go board. Now look at how financial institutions are adopting AI. These are companies that are ahead: real customers, clean exam histories, regulator relationships built over decades. Yet many are deploying AI like desperate players. Prompts that give a different answer every run. Decisions no one can trace back to evidence. Confidential customer data handed raw to models that may train on it. Ask yourself: would your auditor accept an analysis you cannot reproduce? An institution with a lead should never take Hail Mary risk to keep it. The winning move is the simplifying one: AI where the same inputs always produce the same outputs, where every finding cites its evidence, and where PII is redacted before a model ever sees it. That is the architecture we built StandardC on, and it is why our banking clients treat AI as a moat, not a bet. Richard's full essay is worth your time. It covers Go, game theory, and why the bubble has not popped. Read it below.
-
Robert Mann liked thisTHE ALIEN IN THE VAULT Bill Gates told CNN's Fareed Zakaria GPS on Sunday that AI is "a new alien species that is going to be smarter than we are." Most banks are answering that alien with a policy memo. Six months ago, Mike Freiling, PhD (MIT AI Lab, advisor to StandardC) wrote that generative AI is a supernova, "...throwing off new capabilities and new risks almost every day." His conclusion: "The genAI supernova will continue to explode." Both agree on what matters for banks. Nobody is coming to govern this for you. Gates says society has not caught up to how powerful AI is. Freiling is blunter: "Guarantees of confidentiality by third-party vendors cannot be relied upon." The question for every bank CEO, CRO, and BSA officer: If an alien intelligence is already reading your customer files through a chatbot tab, who is watching it? Governing AI in a bank is not a ban. It is four things: 1. Private data is removed before any model sees it. 2. Numbers calculated by code, not generated. 3. Every finding is traced to its source. 4. A human decision on the record. Gates also argued that a monitoring layer over AI can be built without significantly slowing progress. Banks can build their solution this quarter with StandardC Privacy First AI. Read the full article before your next board meeting: Mike Freiling's risk framework and five questions every board should ask about AI. What is your institution doing about the alien in the vault? https://lnkd.in/gBCBNK57 #AIGovernance #Banking #CommunityBanks #CreditUnions #PrivacyFirstAI
-
Robert Mann liked thisScientists have uncovered new clues about the origins of the universe. For generations, asking what preceded the Big Bang was considered a purely philosophical puzzle rather than a scientific inquiry. Because space and time both originated with the Big Bang roughly 13.8 billion years ago, traditional physics suggested there was simply no such thing as 'before.' However, modern cosmologists are finding clever, indirect ways to peer back through the cosmic curtain. By studying subtle fluctuations in the cosmic microwave background radiation and searching for primordial gravitational waves, researchers are beginning to test several highly sophisticated mathematical models of our cosmic prehistory. Among the most prominent theories is the 'no-boundary proposal,' which suggests the universe has no starting edge and that time behaves like space at the cosmic poles, rendering a 'before' meaningless. Alternatively, theories of loop quantum gravity propose a 'Big Bounce,' imagining our universe was born when a previous one collapsed and rebounded. A third intriguing hypothesis envisions a CPT-symmetric 'mirror universe' existing on the other side of the Big Bang, where time flows in reverse. Ultimately, while we may never look directly into this deep past, new technologies are being developed that allow us to final begin testing these theories. And the shape of our current and future cosmos may very well holds the keys to understanding whether we arose from a bounce, a mirror, or a timeless quantum beginning. source: Scoles, S. (2026). What Came Before the Big Bang? Scientific American.
-
Robert Mann liked thisRobert Mann liked thisWhat happens when AI starts learning before the dataset exists? The training data can begin to emerge while learning is already underway. Most AI training follows a familiar sequence: Collect data → build a dataset → train the model The dataset exists first. But self-play opens up a different possibility. One model generates examples. Another model learns from them. As the learner improves, the generator keeps searching for examples near the edge of what the learner can currently handle. Too easy, and there is little to learn. Too difficult, and the example is not useful yet. So the useful training data changes as the learner changes. Generate → learn → generate the next useful challenge → learn again Recent work on Self-Play Pretraining with Zero Data started both the generator and learner from random initialization, without training either one on natural data. The surprising part: the models improved even on datasets they had never been trained on. "Zero data" does not mean learning without examples. The examples are generated during training instead of coming from a natural dataset prepared beforehand. Why does this matter? Useful training data can be expensive, finite, or difficult to anticipate in advance. 📚 High-quality data takes time to collect and curate. 💰 Creating more of it can be expensive. 🎯 What the model needs next can change as its capabilities improve. 🔄 A fixed dataset does not adapt when the learner does. Self-play changes that relationship. Instead of preparing every example in advance, the generator can keep searching for examples useful at the learner’s current level. If this direction matures, it could matter where useful examples are rare, expensive, or hard to anticipate: 🏥 Healthcare: progressively harder simulated cases. 💳 Fraud detection: new fraud patterns and edge cases. 🔐 Cybersecurity: new attack and defense scenarios. 🤖 Robotics: increasingly difficult environments and edge cases. This is different from repeatedly training on old AI-generated outputs. The goal is not to reproduce more of the same data. The generator is actively searching for new examples near the frontier of what the learner can currently handle. This does not mean real-world data goes away. But the architectural idea is important: Training data does not always have to be a fixed input prepared before learning begins. In some systems, generating the next useful training example could become part of the learning process itself. 👍 Like if you found this valuable. 🔔 Follow Surya Gutta for insights on building production AI systems. #SelfPlay #AITraining #SyntheticData #GenerativeAI #AIArchitecture
-
Robert Mann liked thisEveryone's racing to take humans out of the loop. We think that's the mistake of the decade. Today at 2 PM Pacific, StandardC's Robert Baron, Mark Smillie (author of The Feeling Machine), and Mike Freiling, PhD, get into why AI can out-calculate you but will never out-judge you, and what that costs you the moment the stakes are real. "Judgment Without Feeling? Human vs. Artificial Intelligence" Register: https://lnkd.in/g235sWPH #AI #ArtificialIntelligence #HumanInTheLoop
-
Robert Mann liked thisEveryone's racing to take humans out of the loop. We think that's the mistake of the decade. Today at 2 PM Pacific, StandardC's Robert Baron, Mark Smillie (author of The Feeling Machine), and Mike Freiling, PhD, get into why AI can out-calculate you but will never out-judge you, and what that costs you the moment the stakes are real. "Judgment Without Feeling? Human vs. Artificial Intelligence" Register: https://lnkd.in/g235sWPH #AI #ArtificialIntelligence #HumanInTheLoopWelcome! You are invited to join a webinar: Judgment Without Feeling? Human vs. Artificial Intelligence. After registering, you will receive a confirmation email about joining the webinar.Welcome! You are invited to join a webinar: Judgment Without Feeling? Human vs. Artificial Intelligence. After registering, you will receive a confirmation email about joining the webinar.
Experience & Education
-
StandardC
*** * *******
-
****** ******* ***** ***********
***** ******
-
*********
********* *** ***
-
****** *******
-
-
****** ***** **** ******
-
View Robert’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Organizations
-
Angel Faces
Board Member
- Present
Recommendations received
3 people have recommended Robert
Join now to viewView Robert’s full profile
-
See who you know in common
-
Get introduced
-
Contact Robert directly
Other similar profiles
Explore more posts
-
Jon Ingi Bergsteinsson
LIFA Ventures • 12K followers
💰The average cost to bring a 510(k) medical device to market exceeds $31 million ‼️ and nearly 77% of that is tied to regulatory and FDA-related activities 🤯 When I joined Etienne Nichols 🎙️ on the Global Medical Device Podcast by Greenlight Guru, we talked about why so many MedTech startups still underestimate these costs, and what that does to timelines, credibility, and investor confidence. It's rarely the science that breaks the plan, it's the budgeting. Founders often throw "compliance" or "regulatory" into a single line item, then discover too late that those costs multiply with every milestone. We discussed how to think about QMS, clinical, and regulatory expenses early, and how smart planning can prevent painful delays when you hit real-world execution. 🎧 Watch the clip below or catch the full episode: https://lnkd.in/dMR9XPjy #MedTech #MedicalDevices #Regulatory #Clinical #GlobalMedicalDevicePodcast #GreenlightGuru
46
7 Comments -
Suzanne Levy Friedman
Honigman LLP • 2K followers
FDA still hasn't authorized a generative AI-enabled medical device via 510(k), De Novo, or PMA. But a few GenAI devices are reaching the market through a mechanism called TEMPO. Brief background: TEMPO (Technology-Enabled Meaningful Patient Outcomes) is a CDRH pilot launched at the start of 2026. It's built to run alongside CMS's ACCESS model — a new Medicare payment experiment covering 4 chronic care areas: early cardio-kidney-metabolic disease, cardio-kidney-metabolic disease, musculoskeletal conditions, and behavioral health. In ACCESS, participants receive fixed payments for managing a beneficiary's condition and hitting measurable clinical targets. That same focus carries over to TEMPO — digital health devices are accepted into the pilot specifically for an intended use to improve patient outcomes in one of the four ACCESS areas, and participation requires manufacturers to collect and report real-world outcomes data back to FDA. Manufacturers accepted into the program are granted enforcement discretion to commercialize their devices without premarket authorization for the duration of the pilot. Recently, FDA added two GenAI tools: Cadence (hypertension management software) and Limbic (behavioral health) to the pilot. They join Dexcom (continuous glucose monitoring) and SonderMind (a mental health platform), which aren't described as GenAI-based in the same way. This is another example of FDA taking meaningful steps forward to determine how to regulate GenAI, as I've previously noted. Right now, the docket (FDA-2026-N-7874) remains open for stakeholder input on FDA's August 18 discussion paper and it's unclear whether new rulemaking will be needed to shore up FDA's existing authorities. Rather than holding GenAI-enabled devices back until a comprehensive regulatory framework exists, FDA appears willing to let real-world performance data do work that premarket review traditionally does, at least for the TEMPO population. The Agency is thus able to evaluate actual examples that can meaningfully inform its next steps. It remains to be seen: (1) whether TEMPO participation, and the data it generates, end up shaping what FDA's eventual GenAI guidance actually requires; and (2) what additional data beyond the real-world data collected under TEMPO may be needed to secure marketing authorization for pilot participants. #FDA #DigitalHealth #MedTech #GenerativeAI #MedicalDevices
42
2 Comments -
Heath Naquin
University City Science Center • 10K followers
Capital, Taxes and OBBBA Oh My…. Boring I know. Why am I on this? Because ICYMI taxes have just a bit of capital impact too…. Lots of changes this year and on the surface it seems great at least for non clean tech science based companies. In general it seems Federal Tax R&D expensing is (finally) back. Whatever your politics, the OBBBA does deliver some real flexibility (at least for tax purposes) for founders. Small businesses and innovation-stage companies can now fully expense U.S. R&D, retroactively amend for refunds, or catch up deductions in 2025 and 2026. Sounds great. But read the fine print. Always read the fine print. The details related to this can kill your cap runway. We’re talking about the return of Section 174 in the tax code. For the past three years, startups (under $31m in gross receipts) have been crushed by this quiet tax change most never saw coming. I personally know founders impacted by this and the impact was significant. Let’s say high 5 to 6 figures for the ones I know. Short story, Section 174 started forcing R&D costs to be amortized over 5 years vs immediately. Big hit. Recent changes fix that. - Section 174A now restores immediate expensing for domestic research. AND - Applies to tax years beginning after Dec 31, 2024. Great right? Well I was excited till I heard and learned about some crazy thing called Section 280C? Now I’m no accountant but I did a little number crunching and it seems the mistakes on this can be huge. If I’m reading this right, get your SBIR, grants, and commercial R&D tangled, or make the wrong Section 280C election, and you’ll be cutting some pretty hefty checks to the IRS. Basically the rule seems to be if you’re claiming the R&D credit in 2025 and most of you will, Section 280C will force an irrevocable choice on your original return. If you’re burning $2-5M/year on R&D, don’t fly blind with a generic CPA. Get an accountant who actually understands small business elections, funded-research exclusions, and capital efficiency for startups. For years now we’ve been working with Ryan Breen and Andy Cherry KPMG US with companies in our Capital Readiness Program at University City Science Center. Why? Because taxes are fun? No it’s for stuff like this. I’ll be chatting with them on this topic and probably post an article about it because it seems like a big deal. Short story? If this even MIGHT apply to you, do the modeling now. Depending on your timeline and burn, amending or expensing may be your biggest non-dilutive cash event of 2025, but only if you structure it right. If your CPA isn’t aware of either of these? Well that’s a problem. FYI - as I understand it the window closes July 6, 2026 for retroactive elections, but your 2022 statute may expire sooner. Find out. Founders anyone been burned by this? Rest of the community have you seen this issue pop up and how have you handled this? #Section174A #RDTaxCredit #CapitalEfficiency #StartupCFO #CapitalReadiness
7
2 Comments -
Andrew Lombard
TESORO VC • 7K followers
Excited to announce a new collaboration between MDM2 and Tesoro Venture Capital focused on accelerating the commercialization of next-generation healthcare innovation. This initiative is designed to help promising MedTech companies move beyond innovation and into real-world adoption by connecting founders with clinical validation, industry partners, capital, regulatory guidance, manufacturing support, and market access. At Tesoro VC, we believe the biggest opportunity is not simply identifying breakthrough technologies—it is building the ecosystem required to help those technologies reach patients, providers, and markets at scale. Together with MDM2, we are creating a stronger commercialization pathway for healthcare innovators while further strengthening Arizona’s position as an emerging hub for MedTech, AI, advanced technologies, and healthcare innovation. Looking forward to working with founders, healthcare systems, industry leaders, investors, and strategic partners as we build this initiative. Kiran Avancha, PhD Steven Lester MD Aric H. Bopp, CEcD Kathleen Lee Chris Yoo Stuart Broyles, PhD Wes Gullett Mike Self Matthew Puopolo #MedTech #HealthcareInnovation #VentureCapital #Commercialization #DigitalHealth #AI #MedicalDevices #ArizonaInnovation #Startups #TesoroVC
64
8 Comments -
Robert Flores
CyberSweep LLC • 12K followers
MedTech M&A: The FDA’s Cybersecurity Mandate is a $10M+ Hidden Liability. In the high-stakes world of medical device acquisitions, technical checklists are no longer enough. The FDA’s updated cybersecurity requirements mean that a "secure" device today could be a regulatory nightmare tomorrow. At CyberSweep, we’ve seen how overlooked pre-market submission gaps can lead to massive post-close remediation costs: often exceeding $10M in value. Our CyberSweep Portfolio Shield™ doesn't just identify the tech debt; it translates it into a Recommended Deal Adjustment (RDA). We help PE deal teams: 1. Identify FDA compliance gaps during early evaluation (QuickSweep). 2. Quantify the financial impact on future R&D and regulatory hurdles. 3. Protect EBITDA by factoring these risks into the purchase price. Don't let inherited cyber sins erode your exit value. Get the "easy button" for MedTech due diligence. Book a call today or contact us at: 720-794-0931 or info@cybersweep.io
2
-
Bin Yang, CFA FRM
Merdury Biopharmaceutical • 4K followers
🌟 VC News Alert 🌟 Verisoul raises $8.8M for fraud prevention. Series A backed by High Alpha & Lookout Ventures. https://lnkd.in/eK86Vb8v DataLane secures $22.5M Series A for digital identity with Amplify Partners. https://lnkd.in/evmGh_dV Fluency lands $40M in Series A for advertising tech. Supported by Integrity Growth Partners. https://lnkd.in/eJKTmnMQ Thread Bancorp raises $30.5M Series A for fintech. Portage Ventures leads the round. https://lnkd.in/eeNSNxwk Ember LifeSciences nets $16.5M Series A for global healthcare. https://lnkd.in/eP6NrHMC Hoboken Farms secures $4M seed funding. hobokenfarms.com/ Looma receives $10M Series B for retail media. Staley Capital invests. https://lnkd.in/e5BNvihZ Adaptive Security scores $81M Series B for cybersecurity. https://lnkd.in/etmEtzHs Databricks raises $4B Series L valuing it at $134B. https://lnkd.in/ewkGsfAP Nanit closes $50M growth funding. https://lnkd.in/eHyXS3dV Echo secures $35M Series A for AI-powered software. https://lnkd.in/e_cm58t7
2
1 Comment -
Howard Hughes III
Atila Biosystems • 8K followers
Diagnostic velocity is not a clinical detail. It is margin infrastructure. As I lead Atila Biosystems US expansion toward ADLM 2026 in Anaheim, the roadmap is grounded in deployment reality: Extraction free PCR. Under 60 minutes from sample to result. A 90 Minute Moat that keeps decisions, revenue, and patient flow inside the organization. The economics are direct. 2x to 4x revenue per test. 3x margin improvement. 30% lower reagent costs. 50% less manpower. Revenue retained by eliminating the send out tax. This is not a technology showcase. It is an operating model for hospitals, laboratories, urgent cares, and emergency rooms that need faster results without adding proportional labor or cost. At ADLM 2026, we will focus on the questions that determine adoption: Can the workflow deploy cleanly? Can the laboratory sustain velocity? Can leadership measure retained revenue and margin expansion? Can the system scale across sites? The answer must be visible in the numbers. If your organization is evaluating diagnostic deployment, contact me at howard.hughes@atilabiosystems.com. Learn more at www.atilabiosystems.com.
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Robert Mann in United States
-
Robert Mann
San Francisco Bay Area -
Robert Mann
Santa Monica, CA -
Robert Mann
Middleburg, FL -
Robert Mann
Westport, CT
2138 others named Robert Mann in United States are on LinkedIn
See others named Robert Mann